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Resumo 
 
 
O Sistema Nervoso (SN) dos mamíferos é uma rede complexa de células 
especializadas na recepção, transmissão e integração de informação. O 
desempenho de cada um dos subsistemas depende da forma como a 
comunicação entre as diferentes áreas se organiza. Várias ferramentas 
têm vindo a ser desenvolvidas para o efeito, sendo actualmente os 
traçadores neuroanatómicos aquelas de uso mais abrangente. Após 
injecção do traçador seleccionado na área pretendida do SN, este é 
incorporado e subsequentemente transportado de forma retrógrada ou 
anterógrada de acordo com as suas propriedades. O estudo dos sistemas 
supraespinais de controlo da dor tem em muito beneficiado do uso desta 
tecnologia. Várias áreas do encéfalo e, em particular, da formação 
reticular do tronco cerebral, participam na modulação supraspinal da dor. 
O núcleo reticular ventral (VRt) do bolbo raquidiano continua a ser uma 
área pouco explorada do encéfalo, contrariamente ao seu homólogo 
dorsal (DRt), cujo envolvimento na modulação da dor se encontra bem 
estabelecido. No presente trabalho, as projecções encefálicas (eferentes e 
aferentes) do VRt são analisadas no rato, recorrendo-se para tal a 
injecções intracerebrais de traçadores neuronais anterógrados e 
retrógrados, respectivamente o dextrano-amina biotinilado (BDA) e a 
subunidade B da toxina da cólera (CTb). Verificou-se que os neurónios 
do VRt recebem projecções e projectam para áreas do encéfalo 
implicadas no processamento somatosensitivo, emocional e cognitivo da 
dor. Estes resultados corroboram com o papel do VRt na modulação da 
dor. As projecções encefálicas do VRt e DRt para o tronco cerebral são 
em si muito semelhantes, com o VRt a projectar para áreas mais restritas 
do diencéfalo. O papel de cada um dos núcleos na modulação da dor 
poderá estar relacionado com as diferenças observadas nas projecções 
dos núcleos.  
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Abstract 
 
The nervous system (SN) of a mammal is a complex network of cells 
specialized for the reception, transmission and integration of information.  The 
performance of each subsystem depends on how the communication between 
different areas is organized. Several tools have been developed for this purpose, 
being currently the neuroanatomical tracers those of wider use. After selected 
tracer injection in the desired area of the SN, this one is incorporated and 
subsequently transported anterogradely and retrogradely according to their 
properties. The study of the supraspinal pain control systems has greatly 
benefited from the use of this technology. Several areas of the brain and, in 
particular, the reticular formation of the brainstem, are involved in supraspinal 
pain modulation. The ventral portion of the caudal reticular formation (VRt) 
remains a relatively unexplored area of the brain contrary to its dorsal 
counterpart (DRt), whose involvement in pain modulation is well established. 
In the present work, the VRt brain connections (efferent and afferent 
projections) are investigated in the rat, using iontophoretic injections of the 
anterograde tracer biotinylated-dextran amine (BDA) and the retrograde tracer 
cholera toxin-subunit (CTb). It was found that neurons from the VRt receive 
and project to areas of the brain involved in somatosensitive, emotional and 
cognitive pain processing.  
The set of brain projections observed in VRt is compatible with a role in pain 
modulation. VRt and DRt brain projections to the brainstem are similar; 
however, concerning to the diencephalon, VRt has a narrower set of targets. It 
remains unclear how these differences relate to differential roles in pain 
modulation.  
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Index of Abbreviations  
  
The abbreviations are listed in alphabetical order. Each abbreviation is followed by the structure 
name. The nomenclature and abbreviations used to designate brain nuclei and fiber tracts are in 
accordance with those used by Paxinos and Watson (1998) or result from a simplification of it, 
except for a few exceptions assigned with (*). 
 
3 layer 3 of cortex 
3V 3rd ventricle 
7 facial nucleus 
10N dorsal motor nucleus of vagus 
12N hypoglossal nucleus 
 
A 
A5/A7 noradrenaline cells 
ABC avidin–biotin complex 
Amb ambiguous nucleus 
Amy amygdaloid nucleus  
AP area postrema 
APT anterior pretectal nucleus 
Aq aqueduct 
Arc arcuate hypothalamic nucleus 
 
B 
BDA biotinylated dextran 
BST bed nucleus of the stria terminalis 
BSTLV  bed nucleus of the stria terminalis, 
lateral division, ventral part 
BSTMA  bed nucleus of the stria terminalis, 
medial division, anterior part 
 
C  
CC central canal 
CeC central amygdaloid nucleus, capsular 
part 
CeCv central cervical nucleus of the spinal 
cord 
CeL central amygdaloid nucleus, lateral 
division 
CeM central amygdaloid nucleus, medial 
division 
CG central gray 
CL centrolateral thalamic nucleus  
CM central medial thalamic nucleus  
CnF cuneiform nucleus 
CTb cholera toxin subunit B  
Cu cuneate nucleus 
 
D 
DCDp dorsal cochlear nucleus, deep core 
DK         nucleus of Darkschewitsch 
DLPAG dorsolateral periaqueductal gray  
DPGi dorsal paragigantocellular nucleus  
DpMe deep mesencephalic nucleus  
DR dorsal raphe nucleus 
DRt*  dorsal reticular nucleus 
 
E 
ECu external cuneate nucleus 
Eth ethmoid thalamic nucleus 
 
F 
 f fornix 
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G 
Gi gigantocellular reticular nucleus 
Giα gigantocellular reticular nucleus alpha 
part 
GiV gigantocellular reticular nucleus 
ventral part 
GP globus pallidus  
Gr gracile nucleus 
 
H 
HDB nucleus of the horizontal limb of the 
diagonal band 
 
I  
IG indusium griseum 
IMLF interstitial nucleus of the medial 
longitudinal fasciculus 
IO/IOM inferior olive/medial nucleus  
IP  interpeduncular nucleus 
IRt intermediate reticular nucleus 
 
K 
KF Kölliker-Fuse nucleus 
 
L 
LC locus coeruleus 
LH lateral hypothalamus  
LL nuclei of the lateral lemniscus  
LM lateral mammillary nucleus  
LPGi lateral paragigantocellular nucleus 
LPO lateral preoptic nucleus 
LRt lateral reticular nucleus 
LS/LSI lateral septal nuclei/intermediate part 
ltg lateral tegmental tract 
 
M 
Me5 mesencephalic trigeminal nucleus  
mlf medial longitudinal fasciculus 
MnA median accessory nucleus of the 
medulla 
Mo5 motor trigeminal nucleus  
MPO medial preoptic nucleus 
MS medial septal nucleus 
 
N 
NTS*  nucleus tractus solitarius 
 
P 
PAG periaqueductal gray 
PB parabrachial nuclei  
PBS saline phosphate buffer  
PBS-T 0.1 M saline phosphate buffer 
containing 0.3% Triton X-100  
PC paracentral thalamic nucleus 
PCRt parvicellular reticular nucleus 
Pe periventricular hypothalamic nucleus 
PF parafascicular thalamic nucleus  
PH posterior hypothalamic area 
PMn  paramedian reticular nucleus 
Pn pontine nuclei 
PnC pontine reticular nucleus, caudal part 
PnO pontine reticular nucleus, oral part 
PnV pontine reticular nucleus, ventral part 
Po posterior thalamic nuclear group 
Pr prepositus nucleus 
PV paraventricular thalamic nucleus 
PVN* paraventricular hypothalamic nucleus 
py pyramidal tract 
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R 
R red nucleus 
Re reunions thalamic nucleus  
Rh rhomboid thalamic nucleus  
RIP raphe interpositus nucleus 
RMg raphe magnus nucleus  
RPa raphe pallidus nucleus 
ROb  raphe obscurus nucleus 
Rt reticular thalamic nucleus 
RVM rostral ventromedial medulla  
 
S 
SGe supragenual nucleus 
SHi septohippocampal nucleus 
SNC substantia nigra, compact part 
SNR substantia nigra, reticular part 
SolC nucleus of the solitary tract, 
commissural part 
SolM nucleus of the solitary tract, medial 
part 
SolV nucleus of the solitary tract, ventral 
part 
SolVL nucleus of the solitary tract, 
ventrolateral part 
sp5 spinal trigeminal nucleus 
Sp5C spinal trigeminal nucleus, caudal part 
SPF subparafascicular thalamic nucleus 
SpVe spinal vestibular nucleus 
SubC subcoeruleus nucleus 
 
V 
VA ventral anterior thalamic nucleus 
VDB nucleus of the vertical limb of the 
diagonal band 
VL ventrolateral thalamic nucleus  
VLH  ventrolateral hypothalamic nucleus 
VLMlat* lateral portion of the caudal 
ventrolateral medulla 
VM ventromedial thalamic nucleus  
VMH ventromedial hypothalamic nucleus 
VP ventral pallidum 
VPL ventral posterolateral thalamic 
nucleus 
VPM ventral posteromedial thalamic 
nucleus  
VRt*  ventral reticular nucleus 
VTA ventral tegmental area  
 
 
X 
X nucleus X 
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1.1 – Overview of the Nervous System 
What distinguishes the mammals from other animals is the possession of a more or 
less elaborate system for rapidly receiving, integrating and transferring information 
through the body in the form of electrical signals, or nervous impulses. Anatomically, the 
nervous system is divided in the central nervous system (CNS) that comprises the brain 
and spinal cord, and the peripheral nervous system (PNS), where afferent sensory nerves 
transmit information to the CNS, while efferent motor nerves convey instructions from it. 
The fundamental units of the nervous system are the neurons, which working together form 
complex and organized networks for communication and information processing. In 
addition to neurons, there are glial cells that play a supporting role (Kandel et al., 1991) 
and can even modify communication between neurons (Auld and Robitaille, 2003).   
 
1.1.1 Cellular Elements of Nervous System 
The nervous system is made up of more than 100 billion nerve cells. These cells are 
classified as either neurons or glial cells, each of which has several sizes and shapes.  
Neurons are specialized secretory cells composed of a cell body (soma, 
perikaryon), dendrites and an axon (Zigmond et al., 1999).  Neurons usually receive 
messages from other neurons through the dendrites that pick up messages and carry them 
to the neuron's cell body. The axon carries outgoing messages from the cell. Some axons 
are covered with a myelin sheath, made up of glial cells, the Schwann cells at the periphery 
and oligodendrocytes centrally. This asymmetric organization allows the neurons to send 
and receive electrochemical signals and release of signaling molecules. As described in 
Table 1, according to their function within the nervous system, neurons can be divided 
into: a) sensory (afferent) neurons - cells that carry messages from the sense organs to the 
brain or spinal cord, b) motor (efferent) neurons - cells that carry messages from the brain 
or spinal cord to the muscles and glands, and c) interneurons - association neurons carrying 
messages from one neuron to another. 
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Table 1 – The different types of neurons found in the nervous system.  
 Sensory neuron Interneuron Motor Neuron 
Length of 
Fibers 
Long dendrites and short 
axon. 
Short dendrites and short or 
long axon. Short dendrites and long axons. 
Location 
Cell body and dendrite are 
outside of the spinal cord; the 
cell body is located in a 
dorsal root ganglion. 
Interneuron cell bodies are 
always located in the central 
nervous system (CNS). 
Dendrites and the cell body are 
located in the spinal cord; the 
axon is outside of the spinal 
cord. 
Function Conduct impulse to the spinal cord. 
Interconnect the sensory 
neuron with an appropriate 
motor neuron. 
Conduct impulse to an effector 
(muscle or gland). 
Example  
   
 
The three types of neurons are arranged in circuits and networks, the simplest of 
which is the reflex arc. In a simple reflex arc, such as the knee jerk, a stimulus is detected 
by a receptor cell, which is located in the peripheral branch of a sensory neuron. The 
sensory neuron carries the impulse from site of the stimulus to the CNS, where it synapses 
with an interneuron. The interneuron synapses with a motor neuron, which carries the 
nerve impulse out to an effector, such as a muscle, which responds by contracting.  
Glial cells far outnumber neurons, comprises the other major cellular constituent of 
the nervous system. During many years it was thought that functionally, these cells were 
only involved in support, protection and nutrition of neurons, and also to have a facilitatory 
role in conduction for the neurons they surround (Auld and Robitaille, 2003; Ndubaku and 
Bellard, 2008). Lately, it has been shown that these cells have other functions: they 
participate in synaptic transmission and modulation, as key regulators of neurotransmitter 
release, and also as instructors for the development, maintenance, and recovery of synapses 
(Fields and Stevens-Graham, 2002; Auld and Robitaille, 2003; Allen and Barres, 2009). 
Glial cells have also been implicated in other neuron-glial interactions that contribute to 
glial proliferation, differentiation, myelination, among others (Auld and Robitaille, 2003; 
for reviews, see Barres and Raff, 1999; Fields and Stevens-Graham, 2002). 
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There are three types of glial cells in the CNS – astrocytes, oligodendrocytes and 
microglia – and one type in the PNS – Schwann cells – that fill up the spaces between 
neurons with layers of myelin membrane around axons to insulate them for impulse 
conduction (Figure 1) (Kandel et al., 1991; Fields and Stevens-Graham, 2002). 
Astrocytes are known by their star-like shape and by the extensive end-feet on their 
processes. They perform many functions, including biochemical support of endothelial 
cells which form the blood-brain barrier, 
the provision of nutrients to the nervous 
tissue, maintenance of extracellular ion 
balance, and a principal role in the 
repair and scarring process of the brain 
and spinal cord following traumatic 
injuries. Microglia are nonneuronal cells 
found in the brain that respond to injury 
or disease by surrounding cellular 
“trash” and activating inflammatory 
responses. Recent studies have shown 
that microglia can respond to neural 
impulse activity, thus mediating 
neuroimmune interactions, i.e. in chronic 
pain conditions (Watkinis et al., 2001; 
Brodal, 2004). Oligodendrocytes can be 
distinguished from astrocytes by having 
less and thinner processes. They form 
myelin sheaths around axons in the CNS, 
by enveloping them with concentric layers of plasma membrane. In PNS, these functions 
are performed by Schwann cells, forming myelin around PNS axons, ensheathing synaptic 
junctions, and bundling small-diameter axons together (Fields and Stevens-Graham, 2002). 
Myelin forms an insulating sheath around an axon, leaving small areas of axonal 
membrane exposed between successive myelin segments called nodes of Ranvier (Figure 
2) (Watkinis et al., 2001; Poliak and Peles, 2003).  
Figure 1 – Glia-neuron interactions. Different types of 
glia interact with neurons and the surrounding blood 
vessels. Oligodendrocytes wrap myelin around axons to 
speed up neuronal transmission. Astrocytes extend 
processes that ensheath blood vessels and synapses. 
Microglia keeps the brain under surveillance for damage 
or infection (from Allen and Barres, 2009).  
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1.1.2 How Neurons Communicate  
Communication between neurons is dependent on the properties of neuronal 
membranes. In a normal situation, substances will move from areas of high concentration 
to areas of low concentration (osmosis law), until they reach an equilibrium. However, in 
neuronal membranes, differences between intra and extracellular environments, prevents 
molecules to “walk” freely from one side to the other (Anthea et al., 1997). The diffusion 
of these molecules is due to their attachment to proteins that form ions channels through 
which some ions, such as sodium (Na+), chloride (Cl-), potassium (K+) and calcium 
(Ca2+), can diffuse. These transmembrane proteins or pumps transport ions 
bidirectionnaly. For example, the sodium-potassium pump uses transporter molecule that 
forces the Na+ to leave the cell and K+ to entry the cell. Due to these pumps, it is possible 
to say that neurons have at least two moments: a moment where the neuron is “resting”, 
where there is a greater concentration of K+ inside the cell than outside, and a greater 
concentration of Na+, Cl- and Ca2+ outside the cell than inside, and a second one, where 
any changing in the permeability of the membrane will cause an influx or an efflux of these 
Figure 2 - Structure of myelinated axons. Myelinating glial cells, oligodendrocytes in the central nervous 
system (CNS) or Schwann cells in the peripheral nervous system (PNS), form the myelin sheath by 
enwrapping their membrane several times around the axon. Myelin covers the axon at intervals (internodes), 
leaving bare gaps — the nodes of Ranvier. Oligodendrocytes can myelinate different axons and several 
internodes per axon, whereas Schwann cells myelinate a single internode in a single axon (adapted from 
Poliak and Peles, 2003).  
 13 
ions, until the system establish a balance between the inside and the outside of the cell. 
Due to the electrical charge of the ions, this concentration gradient will create an electrical 
potential (about -70 millivolt) between the two sides of the cell. The movement of ions 
across the cell membrane is controlled by both chemical and electrical gradients. To carry 
out any cognitive or motor task, whether memory formation or the execution of a 
movement, neurons will evaluate the inputs arriving in the form of ever-changing 
combinations of synaptic potentials, to determine if and when an action potential should be 
initiated. Neurons are polarized cells characterized by their membrane domains, including 
a single extensive axon and multiple dendritic processes which contain thousands of 
individual synapses (Figure 3a). Synapses are specialized junctional structures through 
which neurons communicate. According to the direction of synaptic transmission, neurons 
can be classified as “pre-” or “post-” synaptic neurons (Figure 3b). Synapses are composed 
of a pre-synaptic terminal, a synaptic cleft and a postsynaptic specialization (Kandel et al., 
1991).  
 The process of synaptic transmission involves neurotransmitter releasing from the 
presynaptic nerve terminal, into the synaptic cleft that interact with postsynaptic membrane 
that gate ion channels (Figure 4). For example, the release of glutamate will open 
postsynaptic Na+ channels, and thus the influx of Na+ will decrease the electrical potential 
at the channels location. This local depolarization is referred to as an excitatory 
Figure 3 – The synapse. a) Simplified representation of a synapse; b) The prefixes "pre-" and "post-" 
reflect the direction of synaptic transmission: presynaptic is the transmitting side (synaptic knob) and 
postsynaptic is the receiving side (dendrite, soma, or effector). 
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postsynaptic potential (EPSP). On the other hand, neurotransmitters as GABA (gamma 
aminobutyric acid) exhibit inhibitory effects, as they interact with receptors to open Cl- and 
K+ channels. The influx of Cl- or exflux of K+ results in an increase in the resting potential 
at the channels location. This local hyperpolarization is referred to as an inhibitory 
postsynaptic potential (IPSP) (Katz, 1969). As illustrated in figure 4, the release of the 
neurotransmitter from the presynaptic terminal involves (1) depolarization of the terminal 
and (2) the presence of ions in the extracellular fluid.  
 
1.1.3 Basic Mechanisms of Axonal Transport 
The mammalian nervous system includes billions of neurons, which are 
interconnected in several neural circuits (Horowitz el al., 1999). Neuronal function and 
survival involves cytoskeletal elements and constant transport of proteins and organelles to 
and from the cell body. The proteins used include kinesin, which is specific for anterograde 
transport, and dynein for retrograde transport (Ström et al., 2008).  
Neuronal cytoskeleton comprises microtubules, actin and intermediate filaments 
(Figure 5). Microtubules and actin filaments provide the neuron with structural support, but 
also give conduits for intracellular transport (Ström et al., 2008; Chevalier-Larsen and 
Holzbaur, 2006). Microtubules provide long-range pathways for fast-anterograde 
movement (from the cell body to the axon terminals) of kinesin motor proteins and the 
Figure 4 – Chemical transmission of a nerve impulse at the synapse (from 2002 Encyclopædia Britannica, 
Inc).  
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retrograde movement (toward cell body) of the dynein motor complex, whereas actin 
filaments are used by myosin motor proteins for short-range, dispersive distribution of 
vesicles, and\or organelles to the cell periphery. Roughly speaking, cargos are transported 
along microtubules and then transferred to the actin cytoskeleton for the final part of their 
journey (Akhmanova and Hoogenraad, 2005; Lansbergen and Akhmanova, 2006). 
As discussed above, anterograde transport is mediated by kinesin-family proteins 
and is used in the translocation of membranous organelles (e.g., mitochondria) and vesicles 
as well as of macromolecules, such as actin, myosin, and clatrin, and some of the enzymes 
necessary for neurotransmitter 
synthesis at the axon terminals. In 
turn, retrograde transport is mediated 
by cytoplasmic dyneins and include 
transport of protein building blocks 
of neurofilaments, subunits of 
microtubules, soluble enzymes and 
materials taken up by endocytosis 
(e.g., viruses and toxins) (Oztas, 
2003).  
The rate of transport is 
specific for each class of substances 
and also independent of electrical 
activity within an axon (Ochs, 1972). 
Fast axonal transport occurs in both 
anterograde and retrograde ways at a 
rate of 0.5–10 μm/sec and includes the 
transport of membrane-bound 
organelles, mitochondria, 
neurotransmitters, channel proteins, multivesicular bodies and endosomes (Shah et al., 
2002). Slow axonal transport occurs only in the anterograde direction at a rate of 0.01–
0.001 μm/sec, and conveys cytoskeletal components, such as neurofilaments, tubulin, and 
actin, as well as proteins such as clathrin and cytosolic enzymes (Heidemann et al., 1981; 
Shah et al., 2002).   
Figure 5 – Axonal transport on microtubules. The motors 
for anterograde and retrograde fast axonal transport are the 
kinesins and dynactin complex proteins, respectively; 
microtubules provide the tracks for these motors. Vesicles 
for transport are sorted and loaded onto transport motors 
both in the cell body and the distal nerve terminal. The 
former are transported not only into the axon but also into 
dendrites. Those in the distal nerve terminal permit uptake 
and axosomatic movement of substances such as trophic 
proteins. Mutations in dynactin (humans), dynein (mice) and 
three different forms of kinesin all provoke motor neuron 
degeneration (from Pasinelli and Brown, 2006). 
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1.3.4 A Brief Approach to Tract-tracing Neuronal Circuits  
 The discovery of the axonal transport triggered years of study into the structural 
basis behind this mechanism. Neuroanatomical tract-tracing methods are considered one of 
the best approaches to study connections between neurons located in different areas of the 
nervous system and to obtain data on the processing of information within a particular area 
(Merighi and Carmignoto, 2002). These anatomical connections can be determined by 
using axonal tracers that rely on intracytoplasmic movement along an axon, by retrograde 
transport towards the neuronal cell body and dendritic tree, or by anterograde transport 
towards a synapse (Köbbert et al., 2000; Lanciego and Wouterlood, 2000; Reiner et al., 
2000). Thus, retrograde axonal transport allows identification of the cells of origin of 
afferent nerve fibers to a specific target zone, whereas anterograde axonal transport show 
us the projection targets of groups of cells to be charted within the CNS (Köbbert et al., 
2000). There is a multitude of tracers available for the study of neuronal connections: a) 
horseradish peroxidase (HRP) or cholera toxin subunit B (CTb) (retrograde tracers) and 
low or high molecular weight dextran amines (anterograde tracers); (b) micelles and/or 
membrane vesicles containing lipophilic dyes; and (c) fluorescein-labeled microparticles 
(for review see for review see Lanciego et al., 1999; Vercelli et al., 1999; Köbbert et al., 
2000). 
Comparing to HRP that is passively taken up by neurons, CTb binds specifically to 
surface receptors of neurons (GM1-ganglioside receptor) and is actively taken up and 
transported by the axons, which may explain the high sensitivity of CTb as a tracer (Luppi 
et al., 1987; George-Chandy et al., 2001). However, CTb receptors are found to be roughly 
distributed either in neurons, or across cell types and also in species that may influence the 
labelling of the neurons according to the species on study or even in the different pathways 
in the same animal (Sabin, 1938). Since its discovery, in 1977, CTb has been strongly 
chosen for retrograde studies. As a tracer, CTb produces intense retrograde labelling from 
small injection sites (Dederen et al., 1994; Datiche et al., 1995; Angelucci et al., 1996; 
Cobos et al., 2003). CTb can also be transported anterogradely, and thus, with a single 
injection it is possible to study the efferent and afferent inputs of a certain area in the CNS 
(Chen and Aston-Jones, 1995).   
Biotinylated dextran amines (BDAs) are one of the tracers mostly used in 
anterograde tract-tracing studies of the nervous system. BDAs are known for their 
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versatility and sensitivity, and depending on their molecular weight, they can be used for 
both anterograde and retrograde studies (Fritzsch, 1993; Kaneko et al., 1996; Medina et al., 
1997a). High-molecular-weight biotinylated dextran amines (BDAs; 10 kDa) provides 
high-quality of labeling of axons and terminals, whereas low-molecular-weight BDAs (3 
kDa) provides a detailed Golgi-like retrograde labeling of neurons. The stability of the 
molecular structure of BDA makes them ideals for long-term storage and examination, and 
their visualizations can be done by simple histochemical methods. Moreover, due to its 
flexibility with fixatives, BDA can be visualized at light or electronic microscopic level 
(for review see Reiner et al., 2000).  
As CTB, BDA can be delivered into the nervous system iontophoretically or 
pressure-injected (Reiner et al., 2000). After injection into the CNS, BDA yields extensive 
and detailed anterograde labeling of axons and terminals (Veenman et al., 1992, 1995; 
Brandt and Apkarian, 1992; Rajakumar et al., 1993). These tracers can CTb toxin B 
fragment, fluorescents dextran amines or intracellular labeling (review see Reiner et al., 
2000).   
For anatomical tracing, cells have to be “alive”, i.e. they cannot be used in fixed 
tissues and for long-distance tracing in juveniles and adults, or require the presence of 
active transport mechanisms instead of simple passive diffusion (Lanciego and 
Wouterlood, 2000; Reiner et al., 2000). Using different techniques of visualization, 
neuronal tracing not only provide information on the morphology or afferent and efferent 
connectivity of neurons, but may also show the synaptic contact of neurons. However, 
there are some problems associated to the conventional tracing methods: 1) because the 
tracers must be delivered to neurons by microinjection or local application, it is difficult or 
impossible to selectively label small populations of neurons of a given phenotype, and 2) 
axons passing through the application region can be damage and become labeled, leading 
to a misinterpretation of results (for review see Lanciego et al., 1999; Vercelli et al., 1999; 
Köbbert et al., 2000). Recently, it was demonstrated that it is possible to use proteins as 
transneuronal tracers when its expression is genetically targeted to a subset of neurons, and 
thus avoid these problems (Horowitz et al., 1999). 
 
 18 
1.2  – Pain Control 
1.2.1 Pain Definition 
For better or worse, we all feel pain (except in some pathologies). The International 
Association for the Study of Pain (IASP) define pain as a sensory and emotional 
experience associated with real or potential injuries, or described in terms of such injuries 
[International Association for the Study of Pain (IASP) - 1994 definition, reviewed in 
2008]. Painful experience exists so the body can recognize that something is threatening it 
and leads to behavior that will remove the organism from the source of potential injury 
(Landrieu et al., 1990). Pain is a key process for our nervous system to learn from and react 
to the environment (King et al., 1997). Certain tissues have specialized sensory receptors, 
called nociceptors that are activated by noxious stimulus to peripheral nerves. Upon 
activation, they transmit the message, by action potentials and neurotransmitters release, to 
the spinal cord dorsal horn for processing and transmission to the brain (Costigan et al., 
2009). It is known that a noxious stimulus can result in a real or potential injury, without 
causing pain. In same cases, noxious stimulus can lead to pain sensation, characterized as 
nociceptive pain. However, painful experience can be spontaneous, such as the 
nonnociceptive pain characterized by the reduction of the receptor thresholds as a result of 
alterations of the central nervous system (CNS) (Casey, 2000). According to this, 
nociception and pain have different means; nociception refers to the neurophysiologic 
manifestations produced by noxious stimulus, while pain involves the perception of an 
aversive stimulus, which requires the capacity of abstraction and the elaboration of sensory 
impulses (Millan, 1999). According to the IASP definition, the relation between pain and 
degree of injury is not obligatory. Alert function is applied only to an acute manifestation, 
i.e., the one that follows damage to the tissue. Acute pain is delimited in time and 
disappears with the settle of the pathological process. On the other hand, chronic pain is 
characterized as persistent, and is associated with chronic pathological processes (Almeida 
et al., 2004). 
 
1.2.2 Peripheral Afferent Fibers 
The most important fibers for pain perception are the axons of afferent nociceptors. 
The afferent nociceptors (Figure 6a) consist of thermal nociceptors that are activated at 
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temperatures above 45ºC (C-fibers) or lower than 5ºC (Aδ -fibers), high-threshold 
mechanical nociceptors that transmit information indicating injurious force on the skin 
(Aδ- and some Aβ-fibers) and polymodal nociceptors that are activated by thermal, 
mechanical and chemical stimuli (C-fibers). According to their diameter, structure and 
conduction velocity, C-fibers are characterized as thin (0.4-1.2 µm in diameter), 
unmyelinated and slowly-conducting (0.5-2.0 m sec-1) fibers; Aδ-fibers as medium (2-6 
µm), myelinated and of intermediate velocity (12-30 m sec-1) fibers; and Aβ-fibers as large 
(>10 µm), myelinated and fast (30-100 m sec-1) fibers (Millan, 1999). Each one of these 
classes encodes sensory information, however they respond differentially to noxious and 
innocuous stimuli, in the sense that the three fibre types transmit non-nociceptive 
information, but only C and Aδ fibers transmit nociceptive information in the normal 
tissue (nociceptors; Giordano, 2005). 
Following a noxious stimulus, primary nociceptive afferents respond with 
differentiated patterns of propagation (Figure 6b). The myelinated Aδ-fibers transmit 
Figure 6 – Different nociceptors detect different types of pain. a) Peripheral nerves include small-diameter 
(A) and medium- to large-diameter (A,) myelinated afferent fibres, as well as small-diameter unmyelinated 
afferent fibres (C); b) The fact that conduction velocity is directly related to fibre diameter is highlighted in 
the compound action potential recording from a peripheral nerve. Most nociceptors are either A or C fibres, 
and their different conduction velocities (6–25 and 1.0 m s-1, respectively) account for the first (fast) and 
second (slow) pain responses to injury (from Julius and Basbaum, 2001).  
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impulses much faster than do the unmyelinated C-fibers. The Aδ-fibers transmit what is 
called the first pain, i.e., sharp and highly localizable. Impulses on C-fibers are responsible 
for what is called second pain. Second pain is slower in arriving, duller and endures after 
the stimulus end (Casey, 2000).  
 
1.2.3 Nociceptors  
To guard against tissue damage, it is important that the body is alerted of 
potentially damaging stimuli. This awareness is attained by a noxious stimulus-detecting 
sensory system (Costigan et al., 2009). Nociceptors are physiological receptors located all 
over the body - skin, internal organs, joints, muscles and tendons. When activated, either 
by noxious stimuli, tissue injury or acute inflammation, the propagation of nociception is 
initiated and afferent information is send to the dorsal horn of the spinal cord where 
synaptic transmission to ascending pathways is subject to modulation by descending 
pathways, local neuronal circuits and different kinds of neurochemicals  (Figure 7) 
(Almeida et al., 2004). Some nociceptors are thinly myelinated (Aδ-fibers) but most are 
unmyelinated (C fibers), and these slowly conducting afferents represent the majority of 
sensory neurons in the PNS. Like all primary sensory neurons in the somatosensory 
system, nociceptors have their cell bodies located in the dorsal root ganglia (DRG) or 
trigeminal ganglia, give rise to a single axon that bifurcates into a peripheral branch that 
innervates peripheral target tissue, and a central axon that enters the CNS to synapse on 
nociceptive second order neurons. Morphologically, nociceptors are similar to other 
neurons; they have a peripheral terminal that transduce external stimuli and initiates action 
potentials, a axon that conducts action potentials, a cell body that controls the identity and 
integrity of the neuron and a central terminal that forms the presynaptic element of the first 
synapse in the sensory pathway in the CNS (Figure 7) (Woolf and Ma, 2007). 
There are three major classes of nociceptors – thermal, mechanical, and polymodal 
– as well as a class classified as silent nociceptors. Aδ mechanical nociceptors, respond to 
noxious mechanical stimuli that damage or threaten to damage tissue. C-polymodal 
nociceptors, react to noxious mechanical, noxious thermal (>44°C) and noxious chemical 
stimuli. Silent (or sleeping) nociceptors, which do not respond to acute noxious stimulation 
of uninjured tissue, become active after tissue injury. The information from nociceptors is 
conveyed by sensory axons, whose cell bodies are in the dorsal root ganglion, to the spinal 
 21 
cord where they synapse onto second-order spinal cord neurons, which transmit the 
information to supraspinal sites (e.g., the thalamus in the brain) (Willis and Westlund, 
1997). 
 
 
1.2.4 From Periphery to Thalamus 
Pain can be understood as a complex entity that does much more than simply 
activate a “pain center”, resulting from complex and  interactive series of mechanisms 
integrated at all levels of the neuroaxis, from the periphery, via the spinal dorsal horn to 
higher cerebral structures (Talbot et al., 1991; Casey et al., 1994; Derbyshire et al., 1997; 
Millan, 1999).  
The dorsal horn of the spinal cord is the location of the first synapse in pain 
pathways, and as such, offers a powerful target for regulation of nociceptive transmission 
(Heinricher et al., 2008). Primary afferent fibers form synapses with dorsal horn sensory 
neurons, which send ascending projecting fibers and make synapses with neurons located 
at supraspinal sites, such as the thalamic nuclei (Zhuo, 2007).  Nociceptive information 
ascends from the spinal cord to the thalamus in the contralateral spinothalamic tract (STT), 
to the medulla and brainstem via the spinoreticular and spinomesencephalic tracts, to the 
hypothalamus via the spinohypothalamic tract, to the supraspinal autonomic control 
centers via the spinohypothalamic tract and to the nuclei in the midbrain, ventroposterior 
lateral and posteriomedial nuclei of the thalamus in the cervicothalamic tract (Millan, 
1999; Willis and Westlund, 1997; Craig, 2003; Pralong et al., 2004).  
 
Figure 7 – The nociceptor.  The operational components of the nociceptor include a peripheral terminal that 
innervates target tissue and transduces noxious stimuli, an axon that conducts action potentials from the 
periphery to the central nervous system, a cell body in the dorsal root ganglion, and a central terminal where 
information is transferred to second order neurons at central synapses (from Woolf, and Ma, 2007).  
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1.2.5 Brainstem Control of Spinal Nociceptive Processing 
The descending pain modulatory system, also known as endogenous pain control 
system, is a well-characterized anatomical network that enables us to regulate nociceptive 
processing in differents situations to produce either facilitation (pro-nociception) or 
inhibition (antinociception) (Hagbarth and Kerr, 1954; Fields and Basbaum, 1999; Treed et 
al., 1999; Heinricher et al., 2009). This modulatory system may facilitate or inhibit 
nociceptive input by three major mechanisms: 1) the modification of synaptic strength in 
the spinal dorsal horn may increase or decrease transmission of nociceptive signals to the 
brain; 2) local dorsal horn interneurons provide both feed-forward and feed-back 
modulation to spinothalamic and spinobulbar projection neurons; and 3) descending 
systems initiating in the brainstem exert top-down modulation of nociceptive input at the 
spinal level (Seifert et al., 2009). 
In 1906 it was demonstrated, for the first time, that brain can modulate in a ‘‘top-
down’’ way spinal cord excitability via a tonically active influence, most of the time 
inhibitory in function. This idea came from Sherrington work that showed that nociceptive 
reflexes were improved after transaction of the spinal cord (Sherrington, 1906). Later on, 
data from 1969 came to emphasized the relevance of this experience by showing that focal 
electrical stimulation in the rat midbrain periaqueductal gray (PAG) produced analgesia 
strong enough to allow surgery without anesthetics or analgesics (Reynolds, 1969). 
Electrophysiological, anatomical, and pharmacological studies have shown that these 
descending influences on spinal nociceptive processing were modulated at the rostral 
ventromedial medulla (RVM), which includes the medial nucleus raphe magnus (Porreca 
et al, 2002; Gebhart, 2004). The RVM receives inputs from the PAG and, in turns, projects 
to the dorsal horn, primarily to the superficial layers, where it can influence spinal 
nociceptive transmission. RVM cells have two major types of neurons that may explain the 
role of the RVM in pain modulation: ON-cells, which facilitate nociception via descending 
axons projecting to the spinal cord (pro-nociception), and OFF-cells, which inhibit 
nociceptive information directly at the level of the spinal cord (antinociception) (Fields et 
al., 1983; Fields and Heinricher, 1985).  
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 The antinociceptive nature of brainstem areas, such as the PAG (Bodnar, 2000), 
the RVM (Mason, 2001), the locus coeruleus (LC; Jones, 1991), the lateral portion of the 
caudal ventrolateral medulla (VLMlat; Tavares and Lima, 2002), the dorsal reticular 
nucleus (DRt; Bouhassira et al., 1992; Almeida et al., 1996; 1999), and the nucleus tractus 
solitarius (NTS; Randich et al., 1988) is well established in the literature. The inhibitory 
antinociceptive nature of the system was latter questioned by the observation of 
pronociceptive effects from areas classically considered as antinociceptive, as the RVM 
(Porreca et al., 2002), the NTS (Wiertelak et al., 1997) and the DRt (Almeida et al., 1996; 
Almeida et al., 1999; Dugast et al., 2003), which play an additional profound nociceptive 
facilitating effect upon acute, inflammatory and chronic pain (Sotgiu et al., 2008). The idea 
of a primary pronociceptive centre in the endogenous pain control system leaded to a new 
concept of pain modulation as a dynamic and flexible process, resulting from balance 
between excitatory and inhibitory actions as the way of adapting to the various unsteady 
pain determinants (Lima and Almeida, 2002). In conclusion, pain control results from the 
balance between inhibiting and facilitating outflows from the brainstem upon spinal 
nociceptive transmissions and a disruption of this balance may constitute the basis for 
Figure 8 – The neural pathway of nociception from primary afferent neurons (PANs) to the superficial 
lamina in the dorsal horn of the spinal cord. Second-order neurons in the dorsal horn convey the noxious 
signal to the brainstem, midbrain, and thalamus. Finally, third-order neurons relay the electrical signal to 
the somatosensory/cingulate cortex and limbic system. Descending modulatory influences arrive in the 
spinal cord dorsal horn (dashed lines) and are derived from the midbrain periaqueductal gray (PAG), the 
locus ceruleus, and the rostral ventromedial medulla (RVM) (from White et al., 2007).  
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chronification of pain (Urban and Gebhart, 1999; Porreca et al., 2002; Vanegas and 
Schaible, 2004; Heinricher et al., 2009). 
 
1.3 – The Brainstem Reticular Formation and Pain 
1.3.1 The Brainstem Reticular Formation 
The reticular formation (RF) is the name given to the collection of small nuclei and 
fiber tracts that run through the core of the brainstem. The RF extends from the caudal 
medulla, where it is continuous with the spinal cord reticular formation, to the 
mesencephalon (Figure 9). The different RF areas receive afferents from most of the 
sensory systems and projects for almost all parts of the nervous system (Hendelman, 
2000). Several studies demonstrated that some subgroups of reticular neurons that receive 
inputs from peripheral receptors, including skin, muscle, bone and joint receptors, integrate 
them and link to the vestibular and cerebellar circuits that will determine posture and 
movement. This information is also integrated by higher brain structures in the visual, 
somatosensory, and motor systems to develop the complex motor patterns of adaptive 
behaviour (Squire, 2003).   
The heterogenic morphology of the RF may explain the multifaceted role in the 
CNS; it exerts important functions on the sleep/wake cycle, regulation of visceral activity, 
control of movement, behaviour, alertness and modulation of pain (Rhoades and Bell, 
2008). According to the function performed, it is possible to delimit different subgroups 
within the RF: 
• Cardiac and respiratory “centers”: subsets of neurons within the medullary reticular 
formation responsible to control the vital functions of heart rate and respiration;  
• Motor areas: the motricity is controlled by both pontine and medullary nuclei of the 
RF via the cortico-reticulo-spinal system;  
• Ascending projecting system: fibers from the RF ascend to the thalamus and project 
to differents nonspecific thalamic nuclei. Here, fibers ascend diffusely to the cerebral 
cortex. This system is related with consciousness and has been termed reticular activating 
system (ARAS); 
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• Pre-cerebellar nuclei: several nuclei in the brainstem placed within the boundaries 
of the RF that project to the cerebellum.  
 A different way to describe this area is according to the spatial positioning of the 
neurons. Topographically, neurons can be arranged in three longitudinal sets, each of them 
with different cytoarchitecture, connections and physiological functions. The lateral group 
is formed by small neurons that receives inputs to the RF, including those from the 
anterolateral (pain and temperature) and trigeminal systems, and the auditory and visual 
input (Kiernan J., 2008). The central group consists of big neurons, and gives rise to long 
ascending and descending fibers pathways, some of them projecting both rostrally into the 
thalamus and caudally to the sacral levels of the spinal cord, thus influencing the axial and 
proximal limb muscles.  Within this group are the nucleus gigantocellularis of the medulla 
and the pontine reticular nuclei, positioned at caudal (lower) and oral (upper) parts, 
forming the two reticulo-spinal tracts. Several staining studies have shown that the medial 
RF contains medium-to-giant-bodied neurons characterized by far-reaching bifurcating 
axons running rostro-caudally, with long branches contacting either the forebrain or spinal 
Figure 9 – The brainstem reticular formation. The location of the reticular formation in relation to some other 
major landmarks at different levels of the brainstem. Neurons in the reticular formation are scattered among 
the axon bundles that course through the medial portion of the midbrain, pons, and medulla (from Purves et 
al., 2007). 
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cord (Scheibel and Scheibel, 1967; Newman, 1965). These cells are referred as projection 
neurons based on the idea that all of them project outside the medial RF. 
Electrophysiological studies have demonstrated that synaptic connections between these 
neurons, formed by terminals of the axons collaterals, are enough to induce excitatory 
post-synaptic potentials (Ito and McCarley, 1987), suggesting a anatomically and 
functionally connection between these projection neurons (Humphries et al., 2006). Some 
evidences suggests a second cell-type in the medial RF, referred as interneurons, however 
not conclusive (Ito and McCarley, 1987). Finally, the midline region is occupied by a 
group of neurons, known as raphe nuclei. The nucleus raphe magnus is one of the nucleus 
of this group, which plays an important role in the descending pain modulatory system 
(Hendelman, 2000).   
 
1.3.2 Neurotransmitters in the Reticular Formation 
Chemical neurotransmitters have been identified and localized in groups of cells 
within the RF, acting in cortical activation and behavioural arousal. Norepinephrine (NE) 
is contained in neurons of the pons and medulla (A1-A7 cells groups). The A5 and A7 
cells groups (in rostral part) projects caudally to the brainstem and spinal cord, whereas the 
A1-A3 cell groups (in caudal part) projects rostrally to the brainstem, hypothalamus and 
basal forebrain. Together, they form the lateral tegmental area, apparently involved in 
hypothalamic regulation and motor control (Moore and Card, 1984). Serotonin or 5-HT is 
contained in neurons located in the midbrain nuclei, dorsal raphe nuclei, and the median 
raphe nuclei (B8 and B9). These neurons project rostrally, innervating nearly the entire 
forebrain, thus suggesting a role in regulation of behaviour state. The acetylcholine (ACh) 
is known as the neurotransmitter of motor neurons, and apparently is associated to 
nonmotor brain areas. Cholinergic neurons may be found either in the pontine nuclei (the 
laterodorsal tegmental nucleus and the pedunculopontine nucleus), projecting to the 
brainstem RF, hypothalamus, thalamus and basal forebrain, or in the medial septum 
(nucleus of the diagonal band and the substantia innominata-nucleus basalis complex), 
which projects to the limbic forebrain, including the hippocampus, and to the neocortex 
(Squire, 2003). In summary, these neurotransmitters are produced by modulatory neurons, 
whereas neurons involved in sensorimotor integration produce either the excitatory 
transmitter glutamate or the inhibitory transmitter GABA (Squire, 2003). 
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1.3.3 The Ascending Reticular Activating Systems Mediates Consciousness and 
Arousal  
The RF receives sensory information from many systems of the body and it is 
broadly interconnected with the cerebellum and the limbic system (Gilman et al., 2003). 
The limbic system consists of a group of deep brain structures, including the hippocampus, 
amygdala, gyrus fornicatus and connecting structures, which support a variety of functions 
such as emotion, behaviour, long term memory, and olfaction. Nearly all the neural fibers 
carrying information into and out of the RF have a crucial role in initiation and control of 
sleep-wake cycle (Siegel, 2002).  
Individual reticular neurons communicate with higher brain areas such as 
hypothalamus, thalamus, cerebellum and spinal cord, making reticular neurons ideal for 
leading the arousal of the brain as a whole. For example, some reticular neurons, if not 
inhibited by other brain areas, are sending continuously impulses (via thalamic relays) to 
the cerebral cortex, keeping it alert and conscious and improving its excitability. This 
function of the RF is called the reticular activating system (RAS) also known as “activating 
system” and its activity is crucial for maintaining the state of consciousness and sleepiness 
(Marieb and Hoehn, 2007). The interest in the sleep-wakefulness cycle begins in 1949, 
when Giuseppe Moruzzi and Horace Magoun discovered that by stimulating the reticular 
formation, they could awaken animals from normal sleep (Butkov and Lee-Chiong, 2007).  
On the same year, Donald Lindsley authored a paper showing that the loss of arousal was 
related to the rostral section of the RF in the mesencephalon (Siegel, 2002). However, in 
1950, a new study on cats, has shown that these animals were capable to be awakened from 
coma with auditory and tactile stimuli, despite the destruction of large neuronal fiber tracts 
that where projecting from the RF to thalamus and then to the cortex (Siegel, 2002).  
The RAS consist of specific thalamic nuclei, parts of the hypothalamus, the ventral 
tegmental area, the parabrachial nuclei, the periaqueductal gray, the nucleus locus 
coeruleus, the raphe nuclei, and the RF itself, most of them involved in arousal and cortical 
tone modulation (Solms and Turnbull, 2002). Impulses coming from ascending sensory 
tracts synapse with RAS neurons, maintaining them active and improving their arousing 
effect on the cerebrum. These pathways involve three to four synapses: a peripheral 
receptor responds to a specific sensory stimulus, as touch, hearting or vision, and transmits 
the information to cells of the RF that projects to the intralaminar nuclei of thalamus, 
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which innervate large areas of the cerebral cortex and limbic system (Rhoades and Bell, 
2008). This system is inhibited by sleep centers located in the hypothalamus and other 
neural regions, and is depressed by alcohol and drugs, including tranquilizers. RAS 
stimulation makes the cortex more alert and aware. However,  any injury to the brain, 
mainly in the brainstem, like head injuries, oxygen deprivation of the brain, drugs, and 
electrolyte changes can influence these centers, resulting in permanent unconsciousness or 
even coma (Marieb and Hoehn, 2007). 
RAS can be divided into two components: the first one, ventral, lower and arousal 
circuit, running parallel to the reticular-thalamic-cortical circuit, and the second one, more 
rostral, is in the basal forebrain, making part of the ventral arousal circuit (for more detail 
see book Marieb and Hoehn, 2007). Besides RAS, there is also a descending element of 
arousal, which function as a physiological activator of the body, and supporting increase in 
activity that normally occurs with waking (Siegel, 2002). These two systems functioning 
together form a positive loop that, if uncontrolled, can result in a severe arousal state 
(Butkov and Lee-Chiong, 2007). In summary, the reticular activating system is responsible 
to transmit sensory input. Nerve impulses, as light and noise, project from the cerebral 
cortex and course via thalamus, stimulating the reticular activating system, resulting in 
arousal and awaken. The sleep-wakefulness cycle results from a feedback system of 
communication between the reticular activating system and the cerebral cortex (Butkov 
and Lee-Chiong, 2007). 
 Additionally, some nuclei of the RF are motor nuclei, which project to motor 
neurons in the spinal cord through the reticulospinal tracts. Some nuclei assist in the 
control of skeletal muscles during coarse limb movement, and other, as vasomotor, cardiac, 
and respiratory centers of the medulla, function as autonomic centers regulating visceral 
motor functions (Marieb and Hoehn, 2007).  
 
 
1.3.4 The Reticular Formation and Nociception 
It is know that nuclei from the reticular formation play an important role in the 
processing of nociceptive information (Bowsher, 1976). This idea is based on anatomic 
studies performed in various species (Villanueva et al., 1988), including man (Bowsher, 
1957; Bowsher, 1962), where most of spinal afferents that travel through the anterolateral 
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quadrant terminate within the brainstem reticular formation. In addition, several areas 
throughout the brainstem reticular formation contain neurons responsive to noxious stimuli 
(Villanueva et al., 1988). For example, neurons recorded within the nucleus 
gigantocellularis are activated by noxious mechanical, electrical, or chemical stimulation 
of their peripheral receptive fields (Casey, 1969; Goldman et al., 1972; Guilbaud et al., 
1973; Gokin et al., 1977; Leblanc and Gatipon, 1974; Pearl and Anderson 1978). On the 
other hand, focal electrical stimulation of this area has been shown to elicit escape 
behaviour (Casey, 1971). Other authors have also reported the existence of neurons 
responding exclusively to noxious mechanical, thermal, or electrical stimulation in more 
caudal areas, such as the caudal bulbar reticular formation (Benton, 1968; Benjamin, 1970; 
Rose, 1975; Mayer and Hill, 1978; Blair, 1985); others have shown that neurons in this 
region can also respond to high threshold visceral stimulation (Gokin et al., 1977) and 
noxious cardiac stimulation (Blair, 1985).  
RF structures have a well-characterized role in descending modulation of pain. For 
instance, the RVM is involved in the development and maintenance of central sensitisation 
and secondary hyperalgesia in animals (Urban and Gebhart, 1999). The PAG and the 
nucleus cuneiformis (NCF) are the main sources of input to the RVM (Basbaum and 
Fields, 1984; Behbehani and Zemlan, 1986), and are in an ideal position to modulate its 
output, i.e. modulate spinal nociception. These nuclei have a physiological substrate for 
bidirectional modulation of pain processing, due to different functionally classes of cells, 
which either facilitate (ON-cells) or inhibit (OFF-cells) nociception (Fields et al., 1983; 
Haws et al., 1989; Heinricher et al., 1987). Later on, other nuclei were shown to have 
anatomical inter-bulbar and bulbo-spinal connections (Lee et al., 1991; Mtui et al., 1993, 
Esteves et al., 1993, Tavares and Lima, 1994, reviewed by Tavares and Lima, 2002, Lima 
and Almeida, 2002; Almeida et al, 2006). Areas like the DRt are involved in modulatory 
actions that are based on a reciprocal circuitry with the spinal cord that allows a rapid 
adaptation to any change occurring in the system (reviewed by Tavares and Lima, 2002, 
Lima and Almeida, 2002, Almeida et al., 2006). 
 
1.3.5 The ventral reticular nucleus  
The ventral reticular nucleus (VRt) remains a relatively unexplored area of the 
caudal medullary reticular formation, contrary to its dorsal counterpart (DRt), whose 
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involvement in pain modulation is well established. The VRt is the caudal continuation of 
the nucleus reticularis gigantocellularis and continues caudally through the deep lamina of 
the spinal dorsal horn. It is located ventrally to the trigeminal subnucleus caudalis and the 
DRt. The potential involvement of VRt in nociceptive processing was initially proposed 
based on the fact that VRt neurons could be activated bilaterally by noxious stimulation of 
the face (Yokota et al., 1991). VRt neurons project mainly to the ventral horn (laminae 
VII-X), via the ventral funiculi and to laminae IV-V (Tavares and Lima, 1994; Villanueva 
et al., 1995) and receives projections from laminae V-VII (Raboisson et al., 1996). 
VRt is also connected with other reticular areas, including the VLM (Cobos et al., 
2003) and the DRT (Almeida et al., 2002). The participation of VRt in pain modulation has 
been demonstrated by electrophysiological studies. The first one reported two different 
groups of VRt neurons: 1) neurons exhibiting spontaneous activity which was unaffected 
by innocuous mechanical stimulation and either unaffected or inhibited by noxious 
peripheral mechanical stimulation and 2) neurons displaying regular, rhythmic activity 
which was synchronous with the rate of ventilation (Villanueva et al., 1988). A second 
study shows that electrical stimulation of the VRt induced analgesia and attenuation of the 
responses of spinal neurons (Aicher and Randich, 1990). A third study reported that 
animals with lesions in VRt seem to feel more pain in behavioral tests, which is the 
opposite of results from lesioning the DRt, thus excluding VRt involvement in the 
facilitation of nociception and suggesting its involvement in antinociception (Almeida et 
al., 1999).   
 
This thesis aims to analyze the overall pattern of brain connections of the VRt, 
using local iontophoretic injections of the anterograde tracer biotinylated-dextran amine 
(BDA) or the retrograde tracer cholera toxin subunit B (CTb).  
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Chapter 2 
 
EXPERIMENTAL PROCEDURES 
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2.1 – Ethical guidelines 
Surgical procedures were performed under pentobarbital anesthesia (50 mg/kg, i.p.) 
on Wistar male rats (Charles River Laboratories, Barcelona, Spain) weighing 280–320 g. 
Animals were placed in a stereotaxic device (Stoelting, Wood Dale, IL, USA) and a 
craniotomy was performed. Coordinates for brain injections followed the stereotaxic 
parameters of (Paxinos and Watson, 1998). The experiments were in accordance with the 
regulation of local authorities for handling laboratory animals and the European 
Community Council Directive 86/609/EEC. The number of animals used and their 
suffering were minimized. 
 
2.2 – Anterograde tracing experiments 
Twenty one  rats received iontophoretic injections (positive direct current of 3.0 
µA; 5 s on/5 s off, lasting for 10 min) of 10% BDA (10,000 MW; Vector Laboratories, 
Burlingame, USA) in the left VRt through glass micropipettes with 15–20m diameter tips. 
After completion of the injection period the micropipettes were left in situ for 10–15 min 
before being slowly retracted to avoid tracer reflux along the pipette tract. Two to three 
weeks later, animals were reanesthetized with eutasil (1 mL/kg body weight) and perfused 
through the ascending aorta, first with 100 mL of saline phosphate buffer (PBS) 0,1 M, pH 
7.2 and then with 1000 mL of 4% paraformaldehyde in PBS. The entire brain was 
removed, immersed in the same fixative for 4 h (RT) and then in 8% sucrose in PBS at 4 
°C for 1–2 days. Coronal sections of the entire brain were serially cut on a vibratome at 50 
µm and incubated with 3.3% H2O2 in order to inhibit endogenous peroxidase. Two in 
every three successive brain sections were immunoreacted with avidin–biotin complex 
(ABC, 1:200; Vector Laboratories) for 1 h and then BDA was revealed with 0.0125% 
diaminobenzidine tetrahydrochloride (DAB; Sigma Immunochemicals, St. Louis, USA) 
and 0.02% H2O2 in Tris–HCl buffer 0.05 M, pH 7.6. Half of these sections were 
counterstained using the formol-thionin technique (Donovick, 1974) and the remaining 
was left without any counterstaining. Sections with and without counterstaining were then 
serially placed in SuperFrost Plus slides (Menzel-Gläser, Braunschweig, Germany), 
dehydrated and mounted in Entellan (Merck, Darmstadt, Germany). 
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2.3 – Retrograde Tracing Experiments 
Twenty Wistar male rats were iontophoretically injected with 1% CTb (List 
Biological Products, Campbell, CA, USA) using the same procedures described above for 
BDA. One week after the injection they were reanesthetized and perfused as above. After 
the inhibition of endogenous peroxidase, serial brain sections were left overnight at 4 ºC in 
a goat antibody against CTb (List Biological Products) at 1:40,000 in 0.1 M PBS 
containing 0.3% Triton X-100 (PBST). After several washes in PBST sections were 
incubated for 1 h in PBST containing a biotinylated anti-goat antibody raised in horse 
(1:200; Vector Laboratories). Sections were washed again in PBST and then incubated in 
PBST containing ABC (1:200). This and subsequent steps were similar to those described 
above for BDA experiments. 
 
2.4 – Image analysis and illustrations 
All the photographic material presented in this study was obtained using a digital 
camera (AxioCam HRc) connected to a microscope (Axioskop 2 Plus), both from Carl 
Zeiss (Göttingen, Germany). Images were captured in a computer using AxioVision 3.1.2.1 
software and the brightness/contrast of each image was improved using Adobe Photoshop 
7.0.1. software. For illustrative proposes, the brain areas receiving efferent projections 
from the VRt were drawn using a sequence of selected formol–Thionin-stained coronal 
sections of one illustrative animal injected with BDA. A motorized microscope 
(Axioplan2, Carl Zeiss) connected to a digital camera (Sony 3CCd DSP, Japan) was used 
to capture the image of the selected brain sections. For each section, the limits of the brain 
nuclei and the labeled fibers were drawn under a 1.25x or 40x objective lens, respectively, 
using Stereo Investigator 4.34 software (MicroBrightField, Inc, Willinston, VT, USA).  
The nomenclature/abbreviations used to designate brain nuclei and fiber tracts are 
in accordance with those used by Paxinos and Watson (1998, 2005) or result from a 
simplification of it. 
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3.1 – Injection sites 
Of the 21 animals that received iontophoretic BDA injections, 5 had injection sites 
that were located in the VRt. All of the BDA injection sites presented a central core of 
labelled neuronal somata and fibers surrounded by a peripheral region containing scattered 
neuronal perikarya with dendrites that extended into the core, resulting from retrograde 
transport. Only those injections whose central dark core and surrounding halo were located 
inside the VRt were considered valid for the present study. Two representative injection 
sites are illustrated in figure 1: animal UMHugo23 (Figure 10A), located medially to 
Sp5C, ventrally to IRt and dorsal medially to LRt, and UMHugo24 (Figure 10B), more 
centred within the nucleus. The injection centers are small and as shown in Figures 1 and 
3, they are found to be located within the boundaries of the VRt as defined by Paxinos.  
As to the CTb injections, from the 20 animals that were injected only 2 had 
injection sites located in the VRt. CTb injection sites appeared as a compact dark zone, 
bounded by a halo in which dark areas intermingled with lighter zones. Nearby the 
peripheral halo were observed a small number of retrogradely labelled cells, probably due 
to uptake from the more central areas. According to previous studies (Ericson and 
Blomqvist 1988; Lima et al., 1991), the injection sites will be delimited only by the central 
core and the peripheral halo. Selection of CTb injection (Figure 11) followed the same 
principle.  
 
B 
A 
A 
Figure 10 - Photomicrographs of representative iontophoretic BDA injections in the VRt. Scale 
bar = 200 μM 
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3.2 – Anterograde Tracing Experiments  
BDA administration to the VRt. Following BDA injections restricted to the VRt, 
anterogradely labelled fibers and terminal boutons appeared along the medulla oblongata, 
pons, mesencephalon, and in some restricted areas of the diencephalon (Figure 12). BDA 
labelled fibers were found mainly ipsilaterally to the injection, with a contralateral 
predominance to diencephalic areas (Figure 13). A detailed analysis of the brain areas 
receiving projections from the VRt will be further presented. 
 
 
 
 
 
 
 
Figure 12 - Camera lucida-like drawings of a representative BDA injection along three 
successive rostro-caudal (A-C) levels of the VRt. Red areas represent the core of the injection. 
The same injection is depicted in the photomicrograph. 
 
Figure 11 - Photomicrographs of a representative iontophoretic CTb injections in the VRt.  Scale 
bar = 500 µM.  
 
A 
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3.2 – Retrograde Tracing Experiments  
CTb-labelled neurons projecting to the VRt were found to be distributed throughout all 
the rostrocaudal extension of the VRt, mainly in the ipsilateral hemisection. A first analysis 
to the brain sections shows that at most caudal part, the higher number of neurons was 
Figure 13 - Camera-lucida-like drawings (A–D) (and two photomicrographs) of four coronal 
brain sections presenting significant amount of BDA labelled fibers originated from the VRt. 
Note that in the black/gray area (scheme D) fibers have not been represented individually due to 
their high density resulting from the proximity to the injection site. RF, reticular formation; PB, 
parabrachial nucleus; RVM, rostroventral medulla; PAG, periaqueductal gray; PF, 
parafascicular nucleus. 
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presented at areas of the brainstem, as PAG and DRt, which are known to be implicated in 
pain modulation.  As to higher areas, such as PVN (Figures 14E, F) and MGP (Figures 
14G, H) CTB-labelled neurons were mainly found ipsilateral to the injection site, despite a 
high labelling in the contralateral part. In subcortical telencephalic areas, a small number 
of labelled neurons was located in the ipsilateral bed nucleus of the stria terminalis (BST; 
Figure 14C), contrary to its contralateral part, where rare or none neurons appeared (Figure 
14D). In the amygdala, a very strong projection was shown to occur, mainly along the 
entire rostrocaudal extent of the central amygdaloid nucleus (CeC), ipsilaterally (Figure 
14I). Contralaterally, none CTb-labelled neurons were found (Figure 14J). In the motor 
cortex, a higher number of neurons were present in the DLO and in secondary (M2) motor 
cortice, mainly on the ipsilateral hemisphere (Figure 14A, B). 
A B 
C D 
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O P 
Figure 14 - Photomicrographs depicting retrogradely labeled cells in areas along the medulla 
oblongata, diencephalon and telencephalon, following CTb injections in the VRt. Panels at the left 
side are ipsilateral to the injection site, and contralateral at the right side. Scale bars = 200μM. All 
the panels are at the same magnification.  
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The present study maps the brain connections of the VRt by the use of anterograde 
and retrograde tracing with, respectively, BDA and CTb. The present results demonstrate 
that neurons from the VRt receive and project to areas of the brain involved in 
somatosensitive, emotional and cognitive pain processing. From all animals that received 
iontophoretic injections, only those cases with injections located within the nucleus with 
minimal involvement of adjacent areas were analysed for the present study.  
The discussion will be organized into four parts: (1) a briefly approach to the tract-
tracing methodology; (2) specificity of the VRt brain projection patterns; (3) a comparative 
study between the VRt and DRt and their integration in the medullary reticular formation; 
and (4) functional considerations concerning the main afferent connections of the VRt.  
 
4.1 – Specificity of the Tract-tracing Methodology 
It is known that axonal tracers are powerful tools for the study of neuronal circuits. 
Tract-tracing studies allow us to study the way in which two or more brain regions are 
connected. Three basic methods are used to apply the tracer material into the area of 
interest: pressure injection, iontophoretic injection and the mechanical insertion of dye 
crystals. Iontophoretic injections are commonly used in neurobiological experiments. This 
way of tracer application allow us to inject locally the tracer by the use of a glass 
micropipette with a small tip diameter (less than 20 JLm), and thus avoid the damage of 
fibers of passage. The tracer molecules are electrically charged, and therefore ejected from 
the micropipette by an applied electrical current created between the muscle of the rat and 
the tracer (for review see Köbbert et al., 2000). On the other hand, it is also important take 
into account the possibility of a deposit formation in the micropipette tip that can scratch 
the tissue and therefore influence the “reading” of the results. To evade this, low currents 
and, thus, long injections are advised (Kratskin et al., 1996).  
In order to demonstrate axonal connections from the VRt, BDA was used as 
anterograde tracer. BDA has recently become the tracer of choice for the most anterograde 
studies, since it reveals excellent terminal morphology from small, localized injection sites, 
and for its large spectrum of survival time (3 days to 3 weeks) (Brandt and Apkarian, 1992; 
Veenman et al. 1992; Rajakumar et al. 1993; Reiner et al. 1993; Wouterlood and Jorritsma-
Byham, 1993; Lanciego and Wouterlood 1994).. BDA is a very powerful tool for 
anterograde tract-tracing studies, and apparently more efficient than PHA-L, when injected 
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into the peripheral nervous system (Novikov, 2001). Knowing that BDA can be 
incorporated into injured dendrites and/or fibers at the injection site, small diameter 
micropipette tips were used during iontophoretic injections, thus avoiding the labelling of 
passing fibers. This was the case of the present study since virtually no labelled perikarya 
were found along the brain of injected rats.  
The nuclei injected with BDA presented a small and delimited injection site with 
intense anterograde labelling. It was also observed a consistent efferent projection pattern 
along the rostral-caudal axis of the reticular formation mainly ipsilateral to the injection. 
Brainstem areas involved in pain modulation as the PB, the RVM and the PAG were also 
found to receive VRt projections. At the diencephalon, BDA labelling was sparser and 
mainly concentrated in the contra lateral thalamic parafascicular nucleus and in the LH. 
As to the retrograde study, CTb has proven to be a very powerful tool for retrograde 
labeling of neurons, and therefore it has been used in several applications. Concerning the 
specificity of CTb as a retrograde tracer, several factors have been taken into account: 
Firstly, the placement of CTb in the VRt; big iontophoretic CTb injections resulted in 
diffuse injection sites, which seem to move dorsally towards to Gr and Cu. On the other 
hand, small iontophoretic injections resulted in restricted and perfectly defined injection 
sites, located within the boundaries of the VRt along the rostrocaudal extension of the 
nucleus. However, almost all of the small injections resulted in few or none labelling. 
Secondly, leakage of CTb: the micropipette track was observed after injection and no 
leakage of the tracer was detected, probably due to the waiting time between the end of 
injection and withdraw of the micropipette.. Thirdly, transneuronal transport: the idea that 
trans-synaptic transport accounted for the labelling of cells receiving projections from the 
VRt can be discarded, since CTb was shown not to be transported transneuronally after 
anterograde transport (Almeida et al., 1993). Lastly, the passing fibers: several studies have 
shown that CTb is not picked up by passing fibers (Lima and Coimbra, 1988; Tavares and 
Lima, 1994). Previous studies have shown that CTb injections into the spinothalamic tract 
didn’t cause spinal labelling (Lima et al., 1991), indicating that CTb is not picked up by 
passing fibers. In addition, it has been demonstrated that, with CTb, anterograde or 
retrograde tracing by passing fibers does not occur when injected iontophoretically (Luppi 
et al., 1990; Angelucci et al., 1996). 
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In table 2 are described some of the problems that we may encounter in studies 
using CTb and with them the possible reason and a possible solution (Conte et al., 2009). 
Problem  Possible Reason  Solution  
Labeling not 
visible or very 
dim 
Tracer conjugates 
are incompatible 
with filter sets on 
the microscope 
Ensure that all filter sets are compatible with the tracers. On our 
system, we have had good results using the FITC filter set for the 
AF 488 conjugate and the Texas red filter for the AF 594 
conjugate (use a Cy3-equivilant filter for AF 555 and a Cy5-
equivilant filter for AF 594). Also ensure that the UV light source 
is of good quality to provide enough light intensity for fluorescent 
labelling. If having problems capturing photos of the labelling, 
increase the exposure time. We typically use a 5-s exposure time 
using a Qimaging Retiga 4000R monochrome camera 
CTB solutions 
were vortexed 
Vortexing CTB results in protein denaturation. When mixing the 
tracer, gently roll the vial to allow gradual saturation of the solid. 
If the tracer was vortexed, the injection site will typically look 
normal, but there will be little evidence of transport 
Improper 
injections 
Ensure that the animal is positioned correctly in the stereotaxic 
device to make sure the coordinates are reliable. If there is a 
complete absence of injection sites (or they are very small and 
faint), then increase the injection volume or the tip diameter. 
Surgical damage to the brain tissue may also cause problems with 
the tracer transport. If no injection site is visible, then a clog in the 
pipette during injection is possible. To recognize and prevent 
clogs, observe the meniscus of the tracer in the pipette when 
injecting. If it does not move, then temporarily increase the 
injection duration/pressure until the clog is removed 
Improper storage 
of the tracer 
The solid form of CTB is stable and can easily be stored at -20 °C 
for about 6 months. Always avoid repeated freeze–thaw cycles. 
Also ensure that the storage freezer is not equipped with an 'anti-
frost' system, as this results in multiple freeze–thaw cycles (an 
easy workaround for this is to place the tracers in an insulated 
container with ice and place the container in the freezer). However, 
the solution form of CTB is less stable and more susceptible to 
contamination. Always ensure the solution is stored at 4 °C for no 
longer than a week. Although this solution could possibly be 
stored at -20 °C for an extended period of time, we advise against 
this. When we have used solutions in the past that had been stored 
at -20 °C, we experienced unreliable results. Furthermore, we also 
experienced significant necrosis at the injection site in some cases. 
We attribute these problems to possible crystallization of the 
tracer. If the solutions have to be stored at -20 °C, ensure that they 
are gradually defrosted 
Improper 
concentrations 
A nonoptimal concentration of the tracer will most likely still show 
a normal injection site. However, labelling patterns may be very 
dim if the concentration is too low. We recommend a starting 
concentration of 1%. If this concentration does not work (assuming 
all other possible problems have been ruled out), increase the 
concentration to a maximum of 2%. For double injections, it is 
good to have different concentrations for each tracer (we typically 
find that the red conjugate is easier to visualize than the green 
conjugate). Note that increased background labelling when using 
higher concentrations has been experienced 
Table 2 – CTb troubleshooting table.  
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High background 
fluorescence 
Improper perfusion If widespread non-neuronal cell labelling throughout the tissue that 
autofluoresce in all spectra is observed, an improper perfusion is 
likely to blame. In particular, increase the duration of the initial 
saline perfusion. Also ensure that the perfusion begins very 
quickly once the animal has been anesthetized before any clotting 
begins 
Fading of cell 
labelling 
Photobleaching as 
a result of 
prolonged 
exposure 
Although Alexa Fluor is claimed to be more photostable than other 
fluorescent dyes, it is still susceptible to photobleaching when 
exposed to intense UV light for long periods of time. Ensure that 
exposure to light at all stages of the procedure (i.e., when the tracer 
is still a solution and when the sections are coverslipped) is 
minimized. We routinely mount two adjacent series of fluorescent 
sections to account for any possible fading: one for viewing the 
labelling patterns and the other for taking quality pictures 
Photobleaching 
due to prolonged 
storage 
The AF dyes are typically more stable over long periods of time 
than other fluorescent dyes. Nevertheless, a slight fade in signal 
when viewing sections that are several months old is still noticed. 
To prevent any possible problems with the results, view samples 
and take pictures as soon as possible. Coverslipping the sections 
with Entellan (or other anti-fade medium) as quickly as possible 
also helps prevent fading 
Anterograde 
labelling present 
This is possibly 
due to a damaged 
injection site 
Whenever necrosis within the injection site is observed, a degree 
of anterograde labelling is present in addition to retrograde 
labelling. To prevent injection necrosis, inject the tracer slowly. 
Typically, one should wait at least 10 s between each shot of tracer 
when using a picospritzer. Also, one should make sure that the 
pressure settings and duration of the picospritzer are not too 
intense. Using smaller pipette tips may also help prevent injection 
damage. Also, try to lower the concentration of the tracer, as high 
concentrations cause necrosis. Furthermore, ensure that the tracer 
is being stored properly. Typically, any damaged injection sites 
when given iontophoretic injections are not observed. 
Nevertheless, if necrosis is observed when using iontophoresis, 
double-check the injection parameters and ensure that the pipette 
tip is not too large. An often-overlooked factor that may cause a 
damaged injection site is the presence of air bubbles in the 
solution. Remove air bubbles by performing several test injections 
onto a piece of X-ray film when determining the picospritzer 
diameter 
 
 
4.2 Specificity of the VRt Brain Projection Patterns  
Several studies have demonstrated the ascending and descending projections of 
areas of the reticular formation in the rat (Fulwiler and Saper, 1984; Vertes and Kocsis, 
1994; Halsell et al., 1996; Almeida et al., 2002; Cobos et al., 2003; Leite-Almeida et al., 
2006).  
As referred before, VRt is the caudal continuation of the nucleus reticularis 
gigantocellularis and continues caudally through the deep lamina of the spinal dorsal horn. 
It is located ventrally to the trigeminal subnucleus caudalis and the DRt. On the coronal 
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plane, the VRt can be delimited from the Cu dorsally, the Sp5C laterally, and 
dorsomedially, from Sol and DRt. Functionally, these areas can be separated individually 
by their particular afferent and efferent connectivity (for more detail see Leite-Almeida et 
al., 2006).  
After BDA injections in the VRt, anterograde labelling was observed bilaterally in 
the caudal medulla, including the NTS and reticular formation areas such as the 
intermediate reticular nucleus (IRt), LRt, VLMlat and, to a lesser extend, the DRt. VRt 
neurons also projects to areas of the rostral medulla, namely to the RVM, despite in less 
number, to the pons, with labelling fibers mostly concentrated in the PB, KF and, to 
mesencephalic nuclei, with PAG as the major receptive area. The LH and PH 
hypothalamic nuclei and the VPL/VPH, Po and VM thalamic nuclei were the diencephalic 
areas to where the VRt projected more prominently. At the most rostral level, the 
VDB/HDB is the only telencephalic area that receives a significant amount of projections 
from the VRt. Areas strongly or moderately targeted by DRt efferents, such as 12, ECu, Gi, 
PCRt, Sp5, Me5, DR, VTA, Arc, LH, L/MPO, PC, Amy, BST, are not a powerful target of 
VRt neurons with rare, if not none, labelling fibers. To confirm these results, was done a 
search to articles about retrograde studies in those particular nuclei.   
It is known that areas described above as receiving projections from the VRt have 
an important role in pain modulation, either in facilitation or inhibition. These include all 
relay areas of the descending hypothalamus–PAG–RVM–dorsal horn circuitry, the 
noradrenergic cell groups LC, A5 and A7, the NTS and nearly all brainstem areas of the 
reticular formation implicated in pain control. Like the DRt, projections to the medial 
thalamus and to the limbic system suggest an involvement of the VRt in the emotional 
processing of pain. To a better understanding, the limbic system is a collection of primitive 
brain structures located on top of the brainstem, under the cortex.  Limbic system 
structures are known to be involved in many of our emotions and motivations, mainly 
those related to survival. Such emotions include fear, anger, and emotions related to sexual 
behaviour. The amygdala and the hippocampus are considered important areas of the 
limbic system that are involved in emotional and cognitive processing. Roughly speaking, 
the amygdala decides what memories must be stored and where, depending on how huge 
an emotional response an event invokes. The hippocampus sends memories out to the 
appropriate part of the cerebral hemisphere for long-term storage and retrieves them when 
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necessary. Its damage may result in an inability to form new memories. The diencephalon, 
which contains the thalamus and hypothalamus, is also included in the limbic system. The 
thalamus is involved in sensory perception and regulation of motor functions (i.e., 
movement), and is connected with areas of the cerebral cortex that are involved in sensory 
perception and movement with other parts of the brain and spinal cord that also have a role 
in sensation and movement. The hypothalamus, although a very small area, plays a very 
important role in regulating hormones, the pituitary gland, body temperature, the adrenal 
glands, and many other vital activities involved in the homeostasis of the body (Kandel et 
al., 1991).  
On the other hand, projections to areas belonging to the extrapyramidal and 
orofacial motor system indicate an involvement in the motor reactions associated with 
pain. Taken together, these results came to reinforce what is already known about this 
nucleus as a medullary center of pain processing and modulation.  
These results were supplemented with CTb injections into the nucleus. Preliminary 
data appointed to retrogradely labelled neurons in several areas along the rostrocaudal 
extension of the brain, mainly ipsilateral to the injection site. However, new CTb injections 
are required to confirm the results.   
 
4.3 The VRt integrated is the medullary reticular formation – a comparative study 
with DRt  
It is known that supraspinal pain control centers that are involved in the modulation 
of spinal nociceptive transmission can exert both an antinociceptive (inhibitory) and a 
pronociceptive (facilitating) role upon nociceptive spinal dorsal horn neurons (reviewed by 
Pertovaara, 2000; Lima and Almeida, 2002; Millan, 2002; Porreca et al., 2002; Gebhart, 
2004; Leite-Almeida et al., 2006). Contrary to the VRt, the role of DRt in pain processing 
and modulation is well explored by anatomical, physiological and behavioural studies (for 
reviews see Villanueva et al., 1996; Lima and Almeida, 2002; Monconduit et al., 2002). 
These two nuclei were recently shown to belong to the supraspinal pain control 
system. Neurons within the DRt are activated mostly by noxious stimulation converging 
from all the body and they were found to be involved in descending projection that will 
increases spinal nociceptive transmission and thus facilitating pain perception (Villanueva 
et al., 1988, 1989; Almeida et al., 1999). On the other hand, the activity of the neurons 
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found in the VRt, remains unaffected or is inhibited by noxious peripheral mechanical 
stimulation (Villanueva et al., 1988). Additionally, it has been reported that the VRt as an 
antinociceptive role, contrary to its dorsal part that is involved in the facilitation of 
nociception (Almeida et al., 1999).  
As to the spinal circuitry, both nuclei are reciprocal connected with the spinal 
dorsal horn laminae implicated in nociception (Almeida et al., 1993; Tavares and Lima, 
1994; Almeida et al., 1995, 2000; Villanueva et al., 1995; Raboisson et al., 1996; Almeida 
and Lima, 1997). Anatomical studies on the ascending and descending DRt pathways have 
shown the presence of a spino-DRt circuit made up of bidirectional connections between 
the dorsal DRt (DRtd) and laminae I and IV–VI, ipsilaterally, and the ventral DRt (DRtv) 
and laminae IV–VI, bilaterally (Lima and Almeida, 2002). As to the ascending spinal 
connections, the VRt receives afferents from laminae V and VII-X (Men6trey et al. 1983; 
Villanueva et al. 1991), whereas regarding the descending connections, VRt project mainly 
to the ventral horn (laminae VII-X), via the ventral funiculi and to laminae IV-V (Tavares 
and Lima, 1994; Villanueva et al., 1995).  
The large spectrum of projections diverging and converging upon the DRt and VRt 
may explain the differences in the way that each one is involved in pain modulation. The 
brain connections of the DRt are extensive as revealed by several tracer studies (Almeida 
et al., 2002; Leite-Almeida et al., 2006). These data came to suggest that the DRt integrates 
information from the somatosensory, antinociceptive, autonomic, limbic, pyramidal and 
extrapyramidal systems while triggering its descending facilitating action upon the spinal 
nociceptive transmission (Almeida et al., 2006). As to the VRt, the main difference when 
compared with the DRt, is concerned with areas as 12, ECu, Gi, PCRt, Sp5, Me5, DR, 
VTA, Arc, LH, L/MPO, PC, Amy, BST, which were strongly or moderately targeted by 
DRt efferents, but constitute “weak” targets for VRt neurons.  
 
4.4 Functional considerations  
Sensorimotor and pain control systems 
A large spectrum of brain areas belonging to the supraspinal pain control system 
project to the VRt and may modulate its activity. Therefore, areas previously shown as 
antinociceptive, such as the motor cortex, basal ganglia, amygdala, thalamus (PF, 
paraventricular thalamic nucleus, sensory thalamus), hypothalamus (LH, Pa, Arc, PH), the 
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PAG-RVM circuit, noradrenergic brainstem areas (LC/subcoeruleus, PBN, KF, A5, Sol, 
A1) and the brainstem reticular formation (DpMe, CnF, DRt, VLMlat) were shown here to 
project to the VRt. On the other hand, areas with both antinociceptive and pronociceptive 
actions, such as the RVM (Wei et al., 1999; Kovelowski et al., 2000) and Sol (Renet al., 
1990; Ness et al., 2000), also project to the VRt. In addition, the contralateral and 
ipsilateral VRt itself have short-projecting neurons inside its borders. Altogether, these 
data suggest that the VRt may also contribute to mediate the balance between inhibiting 
and facilitating nociceptive actions that may, respectively, turn off or turn on the 
descending modulatory action of the supraspinal pain control system upon the spinal 
nociceptive transmission. 
The VRt also receives strong projection from the motor cortex and from 
extrapyramidal areas, as substantia nigra, IO, PCRt and LRt, which may indicate its 
involvement in pain motor reaction. Adding to the fact that VRt projects to the spinal 
dorsal horn (Villanueva et al., 1995), it is possible that the VRt have some control on the 
motor reactions to noxious stimulation, and thus modulates the activity of spinal 
motoneurons. 
 
Autonomic and limbic systems 
The activity of VRt neurons can be influenced by the visceral motor system. The 
visceral (or autonomic) motor system is responsible to control involuntary functions 
mediated by the activity of smooth muscle fibers, cardiac muscle fibers, and glands, and is 
mainly controlled by parts of the brainstem and the hypothalamus (Loewy, 1990). The 
visceral motor system involves afferents from structures such as the dorsal motor nucleus 
of the vagus and the PrL and IL cortices. Other forebrain autonomic centres (reviewed by 
Loewy, 1990) that are involved in the organism homeostasis also projects to the VRt, as 
the BST, Ce, Pa and LH. Most of the above autonomic centres belong also to the limbic 
system (reviewed by Lopes-da-Silva et al., 1990), i.e. the prefrontal cortex (PrL, IL and 
OC), BST, Ce and SI. To the best of our knowledge, these data indicates that the VRT is 
not only involved in the transmission of ascending nociceptive information related to the 
motivational-affective component of pain, but also that its activity can be modulated by the 
reaction triggered by these dimensions of pain.  
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ANNEXE 1 
 
 
Imunocitoquímica para revelar BDA 
 
 
1º DIA – Corte, Recolha e Preservação dos Cortes Histológicos  
 
 
1. Cortes recolhidos em PBS 0.1M, pH=7.2 
 
2. Inibição da peroxidase endógena (330µL de H2O2 em 10mL de PBS 0.1M, pH=7.2) – 10 
min 
 
3. Lavagem em PBS 0.1M, pH=7.2 – 6x10 min 
 
4. Incubação em Complexo Avidina-Biotina vector ELITE em PBS-T, pH=7.2, 1:200 
(preparar com, pelo menos, 30 min de antecedência) – 1 hora 
 
5. Lavagem em PBS-T 0.3%, pH=7.2 – 2x10 min 
 
6. Lavagem em PBS 0.1M, pH=7.2 – 2x10 min 
 
7. Lavagem em tampão TRIS-HCl 0.05M, pH=7.6 – 2x10 min 
 
8. Reacção com DAB (10mg DAB + 20mL tampão Tris-HCl 0.05M, pH=7.6 + 4µL H2O2) – 
20 min 
 
9. Lavagem em tampão TRIS-HCl 0.05M, pH=7.6 – 2x10 min 
 
10. Montagem dos cortes em lâminas de gelatina 
 
11. Secagem na estufa a 37ºC 
 
12. Passagem por xilol 
 
13. Montagem com Eukitt 
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Reagentes 
 
 
1. SORO FISIOLÓGICO A 0.9% 
 
NaCl – 9g 
 
Diluir em 1000mL de água destilada 
 
 
2. PBS 0.02M, PH 7.2-7.4 
 
NaHPO4.12H2O – 14.34g 
NaH2PO4.H2O – 1.31g 
NaCl – 22.5g 
 
Diluir em 2500mL de água destilada 
 
 
3. TAMPÃO TRIS-HCL 0.1M, PH 7.6 
 
TRIS – 12.2g 
Água destilada – 500mL 
HCl 0.1N – 750mL 
 
 
4. ABC 
 
Reagente A – 2 gotas 
Reagente B – 2 gotas 
Tampão fosfatos – 5mL 
 
 
5. DAB 
 
DAB – 10mg  
TRIS – 20mL 
H2O2 – 4µL 
 
 
 
 
 71 
ANNEXE 2 
 
Imunocitoquímica para revelar CTb 
 
1º DIA – Corte, Recolha e Preservação dos Cortes Histológicos  
 
1. Cortes recolhidos em PBS 0.1M, pH=7.2 
 
2. Inibição da peroxidase endógena (330µL de H2O2 em 10mL de PBS 0.1M, pH=7.2) – 10 
min 
 
3. Lavagem em PBS 0.1M, pH=7.2 – 2x10 min 
 
4. Lavagem em PBS-T 0.3%, pH=7.2 – 2x10 min 
 
5. Incubação overnight em anti-CTb 1:40000 em PBS-T, pH=7.2 – mínimo de 8 horas 
 
 
2º DIA – Reacções, Marcação e Montagem das Preparações  
 
1. Lavagem em PBS-T 0.3%, pH=7.2 – 3x10 min 
 
2. Incubação em anticorpo secundário biotinilado Horse anti-goat 1:200 em PBS-T, pH=7.2 – 
1H 
 
3. Lavagem em PBS-T pH=7.2 – 3x10 min 
 
4. Incubação em Complexo Avidina-Biotina vector ELITE em PBS-T, pH=7.2, 1:200 
(preparar com, pelo menos, 30 min de antecedência) – 1 hora 
 
5. Lavagem em PBS-T 0.3%, pH=7.2 – 2x10 min 
 
6. Lavagem em PBS 0.1M, pH=7.2 – 10 min 
 
7. Lavagem em tampão TRIS-HCl 0.05M, pH=7.6 – 2x10 min 
 
8. Reacção com DAB (10mg DAB + 20mL tampão Tris-HCl 0.05M, pH=7.6 + 4µL H2O2) – 
20 min 
 
9. Lavagem em TRIS-HCl 0.05M, pH=7.6 – 2x10 min 
 
10. Montagem dos cortes em lâminas de gelatina 
 
11. Secagem na estufa a 37ºC 
 
12. Passagem por xilol 
 
13. Montagem com Eukitt 
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ANNEXE 3 
 
Coloração pelo Método de Tionina 
 
Os cortes devem secar durante um período de 48h antes de se efectuar o procedimento. 
Todos os procedimentos à temperatura ambiente.  
1. Mergulhar os cortes em acetona ácida (5 min). 
2. Escorre e passar por água destilada. 
3. Mergulhar os cortes na solução de tionina durante o tempo necessário de acordo com o 
grau de coloração pretendido (1 min para uma coloração forte). 
4. Escorre e passar por água destilada. As lavagens devem ser tantas quantas as necessárias 
para uma completa remoção do corante. 
5. Mergulhar os cortes em álcool ácido (1 min).  
6. Escorre e passar por água destilada. 
7. Deixar os cortes secarem, primeiro ao ar e depois na estufa a 37ºC. 
 
Reagentes: 
- Acetona (4 partes) + ácido acético glacial (1 parte); para um total de 250 mL = 200 mL + 
50 mL 
- Tionina 0,1% em formol* a 10%; juntar três gotas de ácido acético glacial por cada 100 
mL.  
* = formaldeído 37% 
- Álcool ácido: álcool isopropílico* a 99% (2 partes) + ácido acético glacial a 10% (1 
parte); para um total de 250 mL = 166mL + 83 mL.  
* = 2-propanol ou isopropanol 
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ANNEXE 4 
 
7. Veda-se a agulha na aorta pinçando o ventrículo. 
Perfusão, Fixação e Pós-Fixação 
 
1. Prepara-se e coloca-se o fixador no sistema de fixação. 
2. Anestesia-se o animal com hidrato de cloral a 35%. 
3. Abre-se a cavidade abdominal, expondo-se a base da caixa toráxica e o diafragma. 
4. Corta-se o diafragma e as costelas, de cada lado dos pulmões, como indica a figura, 
deixando o coração descoberto. 
5. Afasta-se o timo de forma a expor a aorta. 
6. Lanceta-se o ventrículo esquerdo com tesoura fina e introduz-se a agulha até a aorta (vê-
se a agulha à transparência). 
                              
8. Caso seja necessário, corta-se o ventrículo direito e recolhem-se amostras de sangue, 
caso contrário, passa-se para o ponto 9. 
9. Corta-se a aurícula direita e abre-se o sistema com PBS 0.1M, pH=7.2 até deixar de sair 
sangue. 
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10. Passa-se o fixador (paraformaldeído 4%) e fixa-se durante 30 min ou até terem corrido 
500mL de fixador. 
11. Depois de fixado, retira-se a camada muscular que rodeia o pescoço e coluna vertebral, 
com ajuda de um bisturi. 
12. Descasca-se a parte cervical da coluna vertebral utilizando um forcep forte, expondo-se 
a medula espinhal e o bolbo raquidiano. 
13. Descasca-se a calote craniana, expondo o cérebro que é retirado. 
14. O material recolhido é colocado em paraformoldeído 4% durante 2 horas. 
15. Sendo depois conservado até um máximo de 48h numa solução de sacarose: 
- 30% se o corte for efectuado no criostato 
- 8% se for cortado no vibratomo em PBS 0.1M, pH=7.2 
 
Reagentes: 
- Paraformaldeído a 4%  
Paraformaldeído – 340g 
Água destilada (ou PBS 0.1M)- 5950mL 
NaOH – umas gotas 
Diluir o paraformaldeído em 5950mL de água destilada (ou PBS) quase a ferver, até ficar 
límpido. 
- Sacarose  8% 
Sacarose – 80g 
Tampão fosfatos 0.1M, pH=7.2 – 1000mL 
